Literature DB >> 12116003

Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever.

Eric C M Van Gorp1, Tatty E Setiati, Albert T A Mairuhu, Catharina Suharti, Hugo ten Cate Ht, Wil M V Dolmans, Jos W M Van Der Meer, C Erik Hack, Dees P M Brandjes.   

Abstract

The mechanisms contributing to bleeding complications in dengue hemorrhagic fever were studied by investigating the pattern of activation of the coagulation and fibrinolytic systems in 50 children with severe dengue hemorrhagic fever. Thirteen patients (26%) died, and activation of coagulation was most pronounced in the deceased group. Fibrinolysis was also activated, but this activation was relatively weak compared with that of coagulation as a result of persistently high plasminogen activator inhibitor levels. Plasminogen activator inhibitor also prevented a switch from the procoagulant to the profibrinolytic state in lethal dengue hemorrhagic fever, which was further enhanced by an acquired protein C deficiency. The present study is the first to demonstrate such a mechanism in a viral infection. This imbalance between coagulation and fibrinolysis may be used as a prognostic marker, but it may also be a target for future therapeutic intervention. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116003     DOI: 10.1002/jmv.10137

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection.

Authors:  Outi Laine; Lotta Joutsi-Korhonen; Satu Mäkelä; Jussi Mikkelsson; Tanja Pessi; Sari Tuomisto; Heini Huhtala; Daniel Libraty; Antti Vaheri; Pekka Karhunen; Jukka Mustonen
Journal:  Thromb Res       Date:  2011-11-30       Impact factor: 3.944

2.  Plasma levels of inter-alpha inhibitor proteins in children with acute Dengue virus infection.

Authors:  Penelope Koraka; Yow-Pin Lim; Michael D Shin; Tatty E Setiati; Albert T A Mairuhu; Eric C M van Gorp; Augustinus Soemantri; Albert D M E Osterhaus; Byron E E Martina
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

3.  Fibrin formation and lysis studies in dengue virus infection.

Authors:  Rita Marchi; Chandrasekaran Nagaswami; John W Weisel
Journal:  Blood Coagul Fibrinolysis       Date:  2009-10       Impact factor: 1.276

4.  Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1.

Authors:  Anna Cecíllia Quirino-Teixeira; Stephane Vicente Rozini; Giselle Barbosa-Lima; Diego Rodrigues Coelho; Pedro Henrique Carneiro; Ronaldo Mohana-Borges; Patrícia T Bozza; Eugenio D Hottz
Journal:  Blood Adv       Date:  2020-05-12

5.  Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study.

Authors:  Jamie Strampe; Danny A Asogun; Emily Speranza; Meike Pahlmann; Ali Soucy; Sabrina Bockholt; Elisa Pallasch; Beate Becker-Ziaja; Sophie Duraffour; Nahid Bhadelia; Yemisi Ighodalo; Jennifer Oyakhilome; Emmanuel O Omomoh; Thomas Olokor; Donatus I Adomeh; Odia Ikponwonsa; Chris Aire; Ekaete Tobin; Nosa Akpede; Peter O Okokhere; Sylvanus A Okogbenin; George O Akpede; César Muñoz-Fontela; Ephraim Ogbaini-Emovon; Stephan Günther; John H Connor; Lisa Oestereich
Journal:  Lancet Infect Dis       Date:  2021-01-20       Impact factor: 71.421

6.  Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism.

Authors:  A T A Mairuhu; T E Setiati; P Koraka; C E Hack; A Leyte; S M H Faradz; H ten Cate; D P M Brandjes; A D M E Osterhaus; P H Reitsma; E C M van Gorp
Journal:  Thromb J       Date:  2005-11-07

7.  Elevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virus.

Authors:  Virginie Bondu; Ron Schrader; Mary Ann Gawinowicz; Paul McGuire; Daniel A Lawrence; Brian Hjelle; Tione Buranda
Journal:  Viruses       Date:  2015-02-10       Impact factor: 5.048

8.  Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances.

Authors:  Cornelia A M van de Weg; Ralph M H G Huits; Cláudio S Pannuti; Rosalba M Brouns; Riemsdijk W A van den Berg; Henk-Jan van den Ham; Byron E E Martina; Albert D M E Osterhaus; Mihai G Netea; Joost C M Meijers; Eric C M van Gorp; Esper G Kallas
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

9.  Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways.

Authors:  Trai-Ming Yeh; Shu-Hsiang Liu; Kao-Chang Lin; Chieh Kuo; Shu-Yun Kuo; Tzuu-Yuan Huang; Yong-Ren Yen; Rong-Kun Wen; Lien-Cheng Chen; Tsai-Feng Fu
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

10.  Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations.

Authors:  Fernanda A Orsi; Rodrigo N Angerami; Bruna M Mazetto; Susan K P Quaino; Fernanda Santiago-Bassora; Vagner Castro; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  BMC Infect Dis       Date:  2013-07-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.